智飞生物：重组B群脑膜炎球菌疫苗临床申请获得受理

array(1) { [442784]=> array(2) { [2]=> array(3) { [0]=> string(6) "疫苗" [1]=> string(12) "并购重组" [2]=> string(12) "智飞生物" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }